In This Article:
As global markets navigate a complex landscape marked by interest rate adjustments and mixed economic signals, investors are increasingly seeking stable income sources amidst volatility. In this environment, dividend stocks can offer a reliable stream of income, making them an attractive consideration for those looking to balance growth with steady returns.
Top 10 Dividend Stocks
Name | Dividend Yield | Dividend Rating |
Tsubakimoto Chain (TSE:6371) | 4.27% | ★★★★★★ |
Wuliangye YibinLtd (SZSE:000858) | 3.22% | ★★★★★★ |
CAC Holdings (TSE:4725) | 4.76% | ★★★★★★ |
Yamato Kogyo (TSE:5444) | 4.11% | ★★★★★★ |
Guangxi LiuYao Group (SHSE:603368) | 3.23% | ★★★★★★ |
Padma Oil (DSE:PADMAOIL) | 7.43% | ★★★★★★ |
Nihon Parkerizing (TSE:4095) | 3.97% | ★★★★★★ |
China South Publishing & Media Group (SHSE:601098) | 3.80% | ★★★★★★ |
HUAYU Automotive Systems (SHSE:600741) | 4.19% | ★★★★★★ |
E J Holdings (TSE:2153) | 3.88% | ★★★★★★ |
Click here to see the full list of 1868 stocks from our Top Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Abu Dhabi Commercial Bank PJSC
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Abu Dhabi Commercial Bank PJSC, along with its subsidiaries, offers consumer banking, wholesale banking, and treasury and investment services in the United Arab Emirates and internationally, with a market cap of AED75.08 billion.
Operations: Abu Dhabi Commercial Bank PJSC's revenue segments include Retail Banking (AED4.69 billion), Investments and Treasury (AED5.04 billion), and Corporate and Investment Banking (AED5.71 billion), along with Property Management contributing AED745.08 million.
Dividend Yield: 5.5%
Abu Dhabi Commercial Bank PJSC's dividend payments have been volatile over the past decade, posing challenges for income-focused investors. Despite a low payout ratio of 46.9%, which suggests dividends are well covered by earnings, the bank's allowance for bad loans is below ideal levels at 99%. Recent earnings growth, with net income rising to AED 2.39 billion in Q3 2024 from AED 1.94 billion a year ago, provides some optimism for future dividend sustainability.
JW Lifescience
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: JW Lifescience Corporation specializes in providing infusion solutions both in South Korea and internationally, with a market cap of ₩179.78 billion.
Operations: JW Lifescience Corporation generates revenue primarily from its Pharmaceuticals segment, amounting to ₩221.32 billion.